Philip Hampton, presidente di Rbs-Royal Bank of Scotland dal febbraio 2009, sarà dall’anno prossimo il new president of GlaxoSmithKline. hamptons. This was announced by the British pharmaceutical group, explaining that it will join the company's board as a non-executive director from 1 January 2015, from 1 April 2015 he will become vice president and from 1 September non-executive president in place of Christopher Ghent, or even sooner if he is released from other positions in Rbs. In fact, the Scottish bank specifies that Hampton will leave the company during 2015, after a suitable successor has been appointed.
